Initial serum tumor marker change predicts progression-free and overall survival in immune checkpoint blockade treated non-small cell lung cancer

被引：0
|
作者：
Lang, David [1 ]
Horner, Andreas [1 ]
Brehm, Elmar [1 ]
Romain, Silas [2 ]
Kaiser, Bernhard [1 ]
Lamprecht, Bernd [1 ]
机构：
[1] Kepler Univ Hosp, Dept Pulmonol, Linz, Austria
[2] Johannes Kepler Univ Linz, Fac Med, Linz, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2018年 / 130卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P44
引用
收藏
页码：618 / 619
页数：2
相关论文
共 50 条
  • [41] RELATIONSHIP OF PROGRESSION-FREE SURVIVAL, POST-PROGRESSION SURVIVAL AND RESPONSE WITH OVERALL SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER OF INDIVIDUAL-LEVEL
    Imai, Hisao
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    RESPIROLOGY, 2013, 18 : 85 - 85
  • [42] The prognostic value of the tumor shrinkage rate for progression-free survival in patients with non-small cell lung cancer receiving gefitinib
    Park, Dong Il
    Kim, Sun Young
    Kim, Ju Ock
    Jung, Sung Soo
    Park, Hee Sun
    Moon, Jae Young
    Chung, Chae Uk
    Lee, Jeong Eun
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [43] The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib
    Park, Dong Il
    Kim, Sun Young
    Kim, Ju Ock
    Jung, Sung Soo
    Park, Hee Sun
    Moon, Jae Young
    Chung, Chae Uk
    Kim, Song Soo
    Seo, Jae Hee
    Lee, Jeong Eun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2015, 78 (04) : 315 - 320
  • [44] Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World Data
    Ton, Thanh G. N.
    Pal, Navdeep
    Trinh, Huong
    Mahrus, Sami
    Bretscher, Michael T.
    Machado, Robson J. M.
    Sadetsky, Natalia
    Chaudhary, Nayan
    Lu, Michael W.
    Riely, Gregory J.
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2844 - 2853
  • [45] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
  • [46] Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
    Tsai, Yo-Ting
    Schlom, Jeffrey
    Donahue, Renee N.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [47] Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer
    Hallqvist, Andreas
    Rohlin, Anna
    Raghavan, Sukanya
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (06)
  • [48] Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
    Liu, Xiaoming
    Cho, William C.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [49] Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer
    Yang, Jiali
    Chen, Juan
    Wei, Jun
    Liu, Xiaoming
    Cho, William C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (10) : 1209 - 1223
  • [50] Immune checkpoint inhibitors in non-small cell lung cancer: is simultaneous blockade better?
    Eubanks, Jennifer T.
    Ramalingam, Suresh S.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S532 - S535
12345